Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-19
DOI
10.1038/s41375-021-01279-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms
- (2021) Eva N. Hamulyák et al. Blood Advances
- Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm‐associated venous thromboembolism in a large tertiary centre in the UK
- (2020) Natalia Curto‐Garcia et al. BRITISH JOURNAL OF HAEMATOLOGY
- Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms
- (2020) Karlo Huenerbein et al. ANNALS OF HEMATOLOGY
- A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
- (2019) Tarinee Rungjirajittranon et al. BMC CANCER
- Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience
- (2019) Douglas Tremblay et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms
- (2018) Valerio De Stefano et al. Blood Cancer Journal
- Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants
- (2016) Ana Sofia de Freitas et al. ANNALS OF HEMATOLOGY
- High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists
- (2016) V De Stefano et al. LEUKEMIA
- Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
- (2016) V De Stefano et al. Blood Cancer Journal
- Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention
- (2015) Cynthia Wu et al. THROMBOSIS RESEARCH
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
- (2012) Graeme J Hankey et al. LANCET NEUROLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More